edin.ac
Life-saving cancer drug takes next step in clinical development | Institute of Genetics and Cancer | Institute of Genetics and Cancer
A drug candidate for hard-to-treat cancers, developed in the Institute of Genetics and Cancer (IGC) and now licensed to Nuvectis Pharma, has moved to the next stage of clinical trials after successful...